NASDAQ: BTAIBioxcel Therapeutics Inc Stock Ownership - Who owns Bioxcel Therapeutics?
Insider buying vs selling
Have Bioxcel Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when BTAI insiders and whales buy or sell their stock.
BTAI Shareholders
What type of owners hold Bioxcel Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vimal Mehta | 64.99% | 17,595,227 | $19.18M | Insider |
| Bioxcel Holdings Inc | 64.88% | 17,566,750 | $19.15M | Insider |
| Krishnan Nandabalan | 63.14% | 17,094,500 | $18.63M | Insider |
| Rashmi Agarwal | 31.60% | 8,554,945 | $9.32M | Insider |
| Vipin Agarwal | 31.60% | 8,554,945 | $9.32M | Insider |
| Tarun K. Gupta | 31.58% | 8,550,396 | $9.32M | Insider |
| Indu R. Gupta | 31.58% | 8,550,396 | $9.32M | Insider |
| Suganthi Balasubramanian | 31.57% | 8,547,750 | $9.32M | Insider |
| Diwakar Jain | 31.57% | 8,547,300 | $9.32M | Insider |
| Anita Jain | 31.57% | 8,547,300 | $9.32M | Insider |
BTAI vs Biotech Stocks
Bioxcel Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.